Patents Assigned to Pharmaseq
  • Patent number: 6387623
    Abstract: Materials and methods are disclosed for identifying chemical compounds having desired binding properties towards a binding partner of pharmaceutical interest. The method employs transponders associated with the solid phase material used in the assay and a scanner to encode and decode data stored electronically on the transponder. The data stored on the transponder identifies the monomeric building blocks added during the synthesis. The structural identification of synthesized compounds bound to the solid phase is done by decoding the transponder.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: May 14, 2002
    Assignee: Pharmaseq
    Inventor: Wlodek Mandecki